deltatrials
Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06859164

Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis (SHAM-PAIN)

Genicular Artery Embolization for Reducing Pain in Symptomatic Knee Osteoarthritis: A Pilot Randomized Sham-Controlled Study

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Conditions Knee Osteoarthritis Knee Osteoarthritis (Knee OA) Knee Osteoarthritis (OA)
Interventions Genicular Artery Embolization Lipiodol Simple angiogram
Updated 2 times since 2025 Last updated: May 14, 2025 Started: May 1, 2025 Primary completion: Aug 31, 2026 Completion: Nov 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Knee Osteoarthritis and Knee Osteoarthritis (Knee OA) and is currently actively recruiting participants. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Apr 2025 – ~Jun 2025 · 2 months · monthly snapshotNot Yet Recruiting~Jun 2025 – present · 14 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Jun 2025 — Present [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  2. Apr 2025 — Jun 2025 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  • University of Chicago
Data source: University of Chicago

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations